InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more
Market Cap & Net Worth: InspireMD Inc (NSPR)
InspireMD Inc (NASDAQ:NSPR) has a market capitalization of $75.84 Million ($75.84 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22597 globally and #7980 in its home market, demonstrating a 8.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InspireMD Inc's stock price $1.79 by its total outstanding shares 42370995 (42.37 Million).
InspireMD Inc Market Cap History: 2015 to 2026
InspireMD Inc's market capitalization history from 2015 to 2026. Data shows change from $699.12 Billion to $75.84 Million (-60.24% CAGR).
Index Memberships
InspireMD Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #602 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2000 of 3165 |
Weight: InspireMD Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InspireMD Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InspireMD Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.90x
InspireMD Inc's market cap is 15.90 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $699.12 Billion | $2.31 Million | -$15.59 Million | 302649.96x | N/A |
| 2016 | $79.45 Billion | $1.89 Million | -$8.46 Million | 41945.94x | N/A |
| 2017 | $4.13 Billion | $2.76 Million | -$8.44 Million | 1496.26x | N/A |
| 2018 | $5.08 Billion | $3.60 Million | -$7.24 Million | 1411.97x | N/A |
| 2019 | $686.41 Million | $3.72 Million | -$10.04 Million | 184.47x | N/A |
| 2020 | $216.09 Million | $2.48 Million | -$10.54 Million | 86.96x | N/A |
| 2021 | $127.96 Million | $4.50 Million | -$14.92 Million | 28.47x | N/A |
| 2022 | $36.44 Million | $5.17 Million | -$18.49 Million | 7.05x | N/A |
| 2023 | $119.06 Million | $6.21 Million | -$19.92 Million | 19.19x | N/A |
| 2024 | $111.44 Million | $7.01 Million | -$32.01 Million | 15.90x | N/A |
Competitor Companies of NSPR by Market Capitalization
Companies near InspireMD Inc in the global market cap rankings as of March 18, 2026.
Key companies related to InspireMD Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
InspireMD Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, InspireMD Inc's market cap moved from $699.12 Billion to $ 75.84 Million, with a yearly change of -60.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $75.84 Million | +0.56% |
| 2025 | $75.42 Million | -32.32% |
| 2024 | $111.44 Million | -6.41% |
| 2023 | $119.06 Million | +226.74% |
| 2022 | $36.44 Million | -71.52% |
| 2021 | $127.96 Million | -40.78% |
| 2020 | $216.09 Million | -68.52% |
| 2019 | $686.41 Million | -86.50% |
| 2018 | $5.08 Billion | +23.08% |
| 2017 | $4.13 Billion | -94.80% |
| 2016 | $79.45 Billion | -88.64% |
| 2015 | $699.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of InspireMD Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.84 Million USD |
| MoneyControl | $75.84 Million USD |
| MarketWatch | $75.84 Million USD |
| marketcap.company | $75.84 Million USD |
| Reuters | $75.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.